Kintara Therapeutics, Inc.   Report issue

For profit Phase 2 Phase 3
Founded: Vancouver BC Canada (2010)

Organization Overview

First Clinical Trial
2011
NCT01478178
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

DelMar Pharmaceuticals, Inc.